Marksans Pharma (MARKSANS) — AI Technical & Fundamental Analysis
Detected Patterns
No patterns detected
Key Levels
| Level | Price (₹) |
|---|---|
| Entry | ₹255.0 |
| Target | ₹298.0 |
| Stop-Loss | ₹234.0 |
| Support | ₹229.65 |
| Resistance | ₹254.79 |
AI Technical Analysis
{"technical": "MARKSANS has formed a classic, smooth continuation Cup & Handle pattern over the last 3 months. The left rim of the cup peaked at \u20b9254.79, followed by a gradual, rounded correction down to the \u20b9156.89 region (a healthy ~38% depth that quickly recovered), establishing a multi-month U-shaped base. The right rim completed its recovery within 1% of the prior high, hitting \u20b9252.75. Currently, the price is consolidating just below this resistance, forming a tight handle channel over the last two weeks with volume visibly drying up (Volume Ratio of 0.61x). Structurally, the stock is in a stellar multi-timeframe uptrend with the price well above the ascending SMA20, SMA50, and SMA200 lines, showing a perfect golden cross sequence. The RSI14 is currently cooling off from overbought territory down to 68.2 (falling) and the ROC-10 is minorly negative at -0.8%, which perfectly quantifies the expected low-volatility 'weakening' momentum required during the formation of a valid handle before an explosive breakout.", "fundamental": "The company's quarterly financial performance shows an exceptionally strong structural growth trajectory that heavily reinforces the bullish chart structure. Sales have steadily climbed quarter-on-quarter from \u20b9299 cr (Mar 2025) to \u20b9362 cr (Mar 2026). More impressively, net profit has expanded from \u20b938 cr to \u20b992 cr in the same period, demonstrating robust operating leverage and expanding margins despite a minor seasonal dip in December 2025. This consistent fundamental expansion provides strong institutional backing to the multi-month base-building process.", "news": "There are no recent news headlines or corporate announcements available for Marksans Pharma. This lack of recent news indicates that the current price consolidation and handle formation are entirely technically driven by natural market supply-and-demand dynamics, free from temporary news-induced volatility or sentiment spikes.", "pattern_type": "continuation", "momentum_strength": "weakening"}
Fundamentals
Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products[1]
| Quarter | Revenue (Cr) | Net Profit (Cr) |
|---|---|---|
| Mar 2025 | 299 | 38 |
| Jun 2025 | 320 | 48 |
| Sep 2025 | 320 | 100 |
| Dec 2025 | 340 | 61 |
| Mar 2026 | 362 | 92 |
Get alerted when MARKSANS hits key levels
Set price and news alerts for MARKSANS — free on Android.
Download Investonks Free →MARKSANS News Alerts Alert History AI Track Record All AI Picks